featured
The Effect of Bias on Observational Studies Reporting a Lower Risk of Death With SGLT2 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?
Diabetes Care 2018 Jan 01;41(1)6-10, S SuissaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.